US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 31.840
  • -0.710-2.18%
Close Jan 23 16:00 ET
  • 30.500
  • -1.340-4.21%
Pre 04:23 ET
1.03BMarket Cap13.61P/E (TTM)

Collegium Pharmaceutical Key Stats

Collegium Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 178.880M--
--2024/Q4-- / 179.681M--
Nov 7, 20242024/Q3159.301M / 155.573M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 178.880M--
--2024/Q4-- / 179.681M--
Nov 7, 20242024/Q3159.301M / 155.573M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--

Unlock Free Earnings Estimates

Collegium Pharmaceutical Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 23, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data